Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2010, 3(6), 1892-1908; doi:10.3390/ph3061892

A Review of Topical Diclofenac Use in Musculoskeletal Disease

 and *
Received: 22 April 2010; in revised form: 28 May 2010 / Accepted: 8 June 2010 / Published: 11 June 2010
(This article belongs to the collection Non-Steroidal Anti-Inflammatory Drugs)
View Full-Text   |   Download PDF [134 KB, uploaded 11 June 2010]
Abstract: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications for the treatment of musculoskeletal disorders. Osteoarthritis is the most common form of arthritis in humans and its prevalence rises with age. Oral NSAIDs have potential associated toxicities that must be monitored for and can limit the use of these drugs in certain populations including people of older age. Topical NSAIDs are now being recognized as an option for the treatment strategy of osteoarthritis. We review the efficacy and safety of one of the most common topical NSAIDS, topical diclofenac, for the treatment of osteoarthritis.
Keywords: NSAIDs; musculoskeletal; osteoarthritis; diclofenac NSAIDs; musculoskeletal; osteoarthritis; diclofenac
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Nair, B.; Taylor-Gjevre, R. A Review of Topical Diclofenac Use in Musculoskeletal Disease. Pharmaceuticals 2010, 3, 1892-1908.

AMA Style

Nair B, Taylor-Gjevre R. A Review of Topical Diclofenac Use in Musculoskeletal Disease. Pharmaceuticals. 2010; 3(6):1892-1908.

Chicago/Turabian Style

Nair, Bindu; Taylor-Gjevre, Regina. 2010. "A Review of Topical Diclofenac Use in Musculoskeletal Disease." Pharmaceuticals 3, no. 6: 1892-1908.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert